Emergent BioSolutions (EBS) Issues 2022 Guidance; Reports Prelim FY21 Results

Go back to Emergent BioSolutions (EBS) Issues 2022 Guidance; Reports Prelim FY21 Results
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 5.97 +0.33 (5.85%)
Previous Close $5.64    52 Week High $44.38 
Open $5.56    52 Week Low $24.47 
Day High $6.00    P/E 298.50 
Day Low $5.55    EPS $0.02 
Volume 1,165,758